Are aromatase inhibitors associated with higher myocardial infarction risk in breast cancer patients? A Medicare population‐based study

BACKGROUND: Theoretically, the estrogen deprivation induced by aromatase inhibitors (AIs) might cause ischemic heart disease, but empiric studies have shown mixed results. We aimed to compare AIs and tamoxifen with regard to cardiovascular events among older breast cancer patients outside of clinica...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Cardiol
Hlavní autoři: Kamaraju, Sailaja, Shi, Yushu, Smith, Elizabeth, Nattinger, Ann B., Laud, Purushottam, Neuner, Joan
Médium: Artigo
Jazyk:Inglês
Vydáno: Wiley Periodicals, Inc. 2018
Témata:
Clinical Investigations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6344290/
https://ncbi.nlm.nih.gov/pubmed/30443921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.23114
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky